Page last updated: 2024-08-16

s-nitroso-n-acetylpenicillamine and Cardiomegaly

s-nitroso-n-acetylpenicillamine has been researched along with Cardiomegaly in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hunter, JC; Javadov, S; Karmazyn, M; Kilić, A; Rajapurohitam, V; Zeidan, A1
Scholz, PM; Tan, T; Weiss, HR1
Kojda, G; Kottenberg, K; Noack, E; Schrör, K; Stasch, JP1
Butt, E; Drexler, H; Fiedler, B; Gambaryan, S; Heineke, J; Lohmann, SM; Smolenski, A; Trautwein, C; Wollert, KC1

Other Studies

4 other study(ies) available for s-nitroso-n-acetylpenicillamine and Cardiomegaly

ArticleYear
Nitric oxide inhibits endothelin-1-induced neonatal cardiomyocyte hypertrophy via a RhoA-ROCK-dependent pathway.
    Journal of molecular and cellular cardiology, 2009, Volume: 47, Issue:6

    Topics: Actins; Amides; Animals; Animals, Newborn; Cardiomegaly; Cofilin 2; Cyclic GMP; Endothelin-1; Isoenzymes; Models, Biological; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase; Phosphorylation; Protein Transport; Pyridines; Rats; rho-Associated Kinases; rhoA GTP-Binding Protein; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Time Factors; Transcription Factors

2009
Hypoxia inducible factor-1 improves the negative functional effects of natriuretic peptide and nitric oxide signaling in hypertrophic cardiac myocytes.
    Life sciences, 2010, Jul-03, Volume: 87, Issue:1-2

    Topics: Animals; Carbazoles; Cardiomegaly; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Deferoxamine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nitric Oxide; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Up-Regulation

2010
Positive inotropic effect of exogenous and endogenous NO in hypertrophic rat hearts.
    British journal of pharmacology, 1997, Volume: 122, Issue:5

    Topics: Animals; Blood Pressure; Cardiomegaly; Heart; Heart Rate; Hypertension; In Vitro Techniques; Male; Myocardial Contraction; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Nitroglycerin; Norepinephrine; Penicillamine; Rats; Rats, Inbred SHR; Rats, Wistar; S-Nitroso-N-Acetylpenicillamine; Stimulation, Chemical; Vasoconstrictor Agents; Vasodilator Agents; Ventricular Pressure

1997
Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes.
    Hypertension (Dallas, Tex. : 1979), 2002, Volume: 39, Issue:1

    Topics: Animals; Apoptosis; Cardiomegaly; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Cyclic GMP-Dependent Protein Kinases; Down-Regulation; Drug Synergism; Gene Transfer Techniques; Humans; Myocardium; Nitric Oxide; Nitric Oxide Donors; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; S-Nitroso-N-Acetylpenicillamine; Thionucleotides

2002